DCH36_06

N/A

Report date: 2022/02/23 17:13:11
NME

Base Information

Drug NameDCH36_06
Drug Alias NameDCH36_06
ClassificationOther
Mechanisms of ActionHistone acetyltransferase p300 inhibitorscAMP-response element binding protein inhibitors
TargetsHistone acetyltransferase p300cAMP-response element binding protein
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A